Congenital Hematological Disorder Completed Phase 1 Trials for Catridecacog (DB09310)

Back to Congenital Hematological Disorder

Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder

IndicationStatusPhase
DBCOND0081791 (Congenital Hematological Disorder)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01847989Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy VolunteersTreatment
NCT01848002Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy VolunteersTreatment
NCT01082406Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male SubjectsTreatment
NCT00056589Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll DeficiencyTreatment